Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

MSF Nurse Jijo Xavier checks the vitals of a patient at the PL Sharma District Hospital in Meerut city where MSF runs a Hepatitis C project in collaboration with the National Health Mission, providing free services. Photograph by Ravi Mishra
Press release
Press release |
15 March 2016
Intellectual property and trade
India

MSF responds to media reports on Indian Government’s verbal assurance to US groups to discontinue the use of compulsory licence

3 min
Mothers with young children wait for consultation at the MåSF mobile clinic in Pusuguppa, which is a small village in AP along with border of Chhattisgarh. MSF mobile clinic provides free primary health care services which include diagnostic tests, vaccination, malaria and tuberculosis treatment, antenatal and postnatal consultations. Photograph by Sami Siva Photograph by Sami Siva
Press release
Press release |
11 March 2016
Vaccines
India

MSF launches challenge to Pfizer’s patent on the pneumonia vaccine in India, to increase access to more affordable versions

5 min
Shaukat (30) from Abidabad is in his first week of Hep C treatment and is getting tested to see how he is responding to the treatment.  “I have heart problems which makes it very difficult for me to make a decent daily wage. I couldn’t afford the medication on my own so I am happy I get it here for free. My mother-in-law has the same symptoms as me, I will bring her for a checkup.” Photograph by Sa'adia Khan Photograph by Sa'adia Khan
Press release
Press release |
26 February 2016
Hepatitis C
India

Patent challenge hearing on Gilead hepatitis C drug sofosbuvir starts in India

5 min
TB-cabinets are important for an effective walk-in treatment. Here ambulatory treatment, psychosocial counselling for patients and their families, and social packages (nutritional support, hygiene kits and transport money) are provided to help patients adhere to treatment. Photograph by Helmut Wachter
Press release
Press release |
24 February 2016
Tuberculosis

Developing countries hit with high price for important new tuberculosis drug

An unprecedented vaccination campaign is underway in the Central African Republic with aims to reach as many children as possible and prevent some of the most common diseases. Photograph by Pierre-Yves Bernard
Press release
Press release |
24 February 2016
Vaccines

High vaccine prices hamper immunisation efforts in Africa, but are missing from agenda of key vaccination conference

5 min
Veena Panchal lives in Andheri East, a crowded suburb of Mumbai, along with her two children. She found out in 2002 that she was HIV positive, after the death of her husband from HIV/AIDS. Her two children are HIV negative. Photograph by Subodh Pakhare
Press release
Press release |
10 February 2016
HIV/AIDS
India

Pharma company Viiv’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India

5 min
Metro advertisements for Doctors Without Borders, 2015 Photograph by Drew Angerer
Press release
Press release |
02 February 2016
Intellectual property and trade
New Zealand

There’s still time to stop the TPP from cutting off the critical lifeline of affordable generic medicines

In the laboratory of Maradi, a team of a dozen people receive about 1,200 specimens (blood, urine/stool, mothers' breast milk...) every week, to be analyzed for the trial. The specimens taken in the morning, whether by the medical teams at the five health centres involved in the study or by the field workers or assistant nurses at the patients' homes, arrive at the laboratory in Maradi in the early afternoon. Photograph by Séverine Bonnet Photograph by Séverine Bonnet
Press release
Press release |
01 February 2016
Vaccines

Pfizer attempts to mislead public over research and development ‘facts’ with Tube ads

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury